Microbial cell membrane, biofilm extracellular polymeric substance matrix, and intracellular DNA

This target represents a multi-component assembly of microbial structures essential for survival, pathogenicity, and resistance. The microbial cell membrane provides structural integrity and acts as a selective barrier, often targeted by lipopeptides and polymyxins that disrupt lipid organization (Clinical Microbiology Reviews, 2015). The biofilm extracellular polymeric substance (EPS) matrix consists of polysaccharides, proteins, and extracellular DNA (eDNA) that shield microbial communities from environmental stress and host immune responses (Nature Reviews Microbiology, 2010). Intracellular DNA serves as the blueprint for all cellular processes and is a critical site for antimicrobial intervention, where agents like metronidazole cause direct strand breakage (StatPearls, 2023). Drugs targeting these components often work by physically disrupting the lipid bilayer, enzymatically breaking down the protective EPS matrix to enhance antibiotic penetration, or directly damaging genetic material to prevent replication. Because these structures are fundamental to microbial life, they are primary focuses for treating persistent and multi-drug resistant infections. However, the complexity of these targets, particularly in biofilms, presents significant therapeutic challenges including poor drug penetration and the risk of host toxicity.

Other names

Microbial cell envelopeBiofilm matrixExtracellular polymeric substances (EPS)Genomic DNAeDNA

The mechanism of action involves the physical disruption of the microbial lipid bilayer, the enzymatic hydrolysis of extracellular DNA and polysaccharides within the biofilm matrix, and the induction of covalent DNA adducts or strand breaks in intracellular genetic material.